Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had breast cancer or a gynaecological cancer (such as ovarian, endometrial, cervical, vulvar, or vaginal cancer), including those whose cancer has come back
- People who have finished their main cancer treatment, which may have included surgery, radiation, chemotherapy, or a combination of these
- People aged 18 or older
- People who are currently on or are planning to start a long-term maintenance treatment lasting more than 3 months during the study period (for example, hormone-blocking therapy, targeted therapies, or immunotherapy) are still eligible to participate
- People who have had a previous cancer diagnosis are still eligible to participate
- People who have had previous cancer treatment, including chemotherapy for a prior cancer, are still eligible to participate
- People who have a stoma are still eligible to participate
- People who are currently taking part in another experimental drug trial are still eligible to participate
- People who are using complementary therapies, including mistletoe therapy, are still eligible to participate
- People who are pregnant are still eligible to participate
- People who agree to take part and sign a consent form
Who may not be able to join:
- People who have language difficulties or cognitive (thinking or understanding) challenges that would make it too hard to take part in the study
- People with serious physical or mental health conditions that would prevent them from participating
- People who are not able to give their own informed consent to join the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Viola Heinzelmann-Schwarz, Prof. MD, University Hospital of Basel
Phone: +41 61 32 85885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of Study Conduct (Composite Outcome)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.